Peritoneal dialysis (PD) has been a successful modality for chronic renal replacement therapy for more than 30 years. Icodextrin has been a major addition to the management of ultrafiltration in peritoneal dialysis (PD). Currently, it is widely used in PD because of several long-term complications of solutions containing high glucose. Although the efficacy and safety of Icodextrin is well known, it may cause allergic reactions and aseptic peritonitis. We report an interesting PD patient with findings that do not correspond to the complications previously reported due to Icodextrin.